From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

Andrea Rubboli; Elena Barbaresi; Bianca Rocca

doi:10.1007/s10557-019-06903-y

From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

Andrea Rubboli
, Elena Barbaresi
, Bianca Rocca

Ospedale S. Maria delle Croci

Research output: Contribution to journal › Article › peer-review

Abstract

NA

Original language	English
Pages (from-to)	143-144
Number of pages	2
Journal	Cardiovascular Drugs and Therapy
Volume	34
DOIs	https://doi.org/10.1007/s10557-019-06903-y
Publication status	Published - 2020

Keywords

Anticoagulants
Atrial Fibrillation
Clinical Decision-Making
Coronary Artery Disease
Drug Therapy, Combination
Drug Utilization
Dual Anti-Platelet Therapy
Fibrinolytic Agents
Hemorrhage
Humans
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Practice Patterns, Physicians'
Risk Factors
Treatment Outcome

Access to Document

10.1007/s10557-019-06903-y

Cite this

@article{1714afd05e9b4af5a2821d2e674a652d,

title = "From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention",

abstract = "NA",

keywords = "Anticoagulants, Atrial Fibrillation, Clinical Decision-Making, Coronary Artery Disease, Drug Therapy, Combination, Drug Utilization, Dual Anti-Platelet Therapy, Fibrinolytic Agents, Hemorrhage, Humans, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Practice Patterns, Physicians', Risk Factors, Treatment Outcome, Anticoagulants, Atrial Fibrillation, Clinical Decision-Making, Coronary Artery Disease, Drug Therapy, Combination, Drug Utilization, Dual Anti-Platelet Therapy, Fibrinolytic Agents, Hemorrhage, Humans, Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Practice Patterns, Physicians', Risk Factors, Treatment Outcome",

author = "Andrea Rubboli and Elena Barbaresi and Bianca Rocca",

year = "2020",

doi = "10.1007/s10557-019-06903-y",

language = "English",

volume = "34",

pages = "143--144",

journal = "Cardiovascular Drugs and Therapy",

issn = "0920-3206",

publisher = "Springer",

}

From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention. / Rubboli, Andrea; Barbaresi, Elena; Rocca, Bianca.
In: Cardiovascular Drugs and Therapy, Vol. 34, 2020, p. 143-144.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

AU - Rubboli, Andrea

AU - Barbaresi, Elena

AU - Rocca, Bianca

PY - 2020

Y1 - 2020

N2 - NA

AB - NA

KW - Anticoagulants

KW - Atrial Fibrillation

KW - Clinical Decision-Making

KW - Coronary Artery Disease

KW - Drug Therapy, Combination

KW - Drug Utilization

KW - Dual Anti-Platelet Therapy

KW - Fibrinolytic Agents

KW - Hemorrhage

KW - Humans

KW - Percutaneous Coronary Intervention

KW - Platelet Aggregation Inhibitors

KW - Practice Patterns, Physicians'

KW - Risk Factors

KW - Treatment Outcome

KW - Anticoagulants

KW - Atrial Fibrillation

KW - Clinical Decision-Making

KW - Coronary Artery Disease

KW - Drug Therapy, Combination

KW - Drug Utilization

KW - Dual Anti-Platelet Therapy

KW - Fibrinolytic Agents

KW - Hemorrhage

KW - Humans

KW - Percutaneous Coronary Intervention

KW - Platelet Aggregation Inhibitors

KW - Practice Patterns, Physicians'

KW - Risk Factors

KW - Treatment Outcome

UR - http://hdl.handle.net/10807/169233

U2 - 10.1007/s10557-019-06903-y

DO - 10.1007/s10557-019-06903-y

M3 - Article

SN - 0920-3206

VL - 34

SP - 143

EP - 144

JO - Cardiovascular Drugs and Therapy

JF - Cardiovascular Drugs and Therapy

ER -

From the Choice of a Regimen to the Choice of an Intensity: Changing Perspective in the Antithrombotic Therapy of Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this